E. coli News and Research

RSS

E. coli or Escherichia coli is the name of a type of bacteria that lives in your intestines. Most types of E. coli are harmless. However, some types can make you sick and cause diarrhea. One type causes travelers' diarrhea. The worst type of E. coli causes bloody diarrhea, and can sometimes cause kidney failure and even death. These problems are most likely to occur in children and in adults with weak immune systems. You can get E. coli infections by eating foods containing the bacteria. To help avoid food poisoning and prevent infection, handle food safely. Cook meat well, wash fruits and vegetables before eating or cooking them, and avoid unpasteurized milk and juices. You can also get the infection by swallowing water in a swimming pool contaminated with human waste. Most cases of E. coli infection get better without treatment in 5 to 10 days.

Researchers develop biosensors to accurately detect E. coli in meat products

The sensors developed by the NTC overcome all these inconveniences. They make it possible to detect one of the greatest enemies of the sector, the Eschericia Coli bacteria, quickly, affordably and with great accuracy.

6 Sep 2019

Newly discovered resistance-spreading mechanism is independent of the use of antibiotics

Bacteria are becoming increasingly resistant to common antibiotics. Often, resistance is mediated by resistance genes, which can simply jump from one bacterial population to the next.

5 Sep 2019

FDA recommends health care facilities to transition away from fixed endcap duodenoscope models

Today, the U.S. Food and Drug Administration is recommending that duodenoscope manufacturers and health care facilities transition to different types of duodenoscopes that may pose less risk to patient safety.

31 Aug 2019

Diet can alter efficacy of type-2 diabetes drug via its action on gut bacteria, study shows

Research published in Cell on 29th August by the groups of Filipe Cabreiro from the MRC London Institute of Medical Sciences and Imperial College and Christoph Kaleta from Kiel University in Germany has demonstrated that diet can alter the effectiveness of a type-2 diabetes drug via its action on gut bacteria.

30 Aug 2019

Molecular mechanism by which human stomach pathogen is attracted to bleach revealed

Researchers at the University of Oregon have uncovered a molecular mechanism by which the human stomach pathogen Helicobacter pylori is attracted to bleach, also known as hypochlorous acid or HOCI.

30 Aug 2019

Promising vaccine may protect against the Klebsiella superbug

A powerful superbug, a hypervirulent form of the bacteria Klebsiella pneumoniae, is a very difficult to curb infection. It causes a variety of infections including rare but life-threatening liver, respiratory tract, bloodstream and other infections.

28 Aug 2019

Researchers discover pivotal role for bacterial sex in evolution of mammalian microbiome

In a pioneer study now published in Proceedings of the National Academy of Science - USA, the research team led by Isabel Gordo, from the Instituto Gulbenkian de Ciência, in collaboration with researcher Michael Lässig of Cologne University, used healthy mice to study real-time gut colonization and discovered a pivotal role for bacterial sex in the evolution of the mammalian microbiome.

25 Aug 2019

Mysterious lung disease linked to vaping spreads across 14 US states

The CDC is investigating a series of cases of mysterious, severe lung disease. The cause is not known, but every patient uses an e-cigarette.

21 Aug 2019

UVA scientists reveal how E. coli knows to cause the worst possible infections

A pair of University of Virginia School of Medicine scientists have revealed how E. coli seeks out the most oxygen-free crevices of your colon to cause the worst infection possible.

19 Aug 2019

Research shows how E. coli knows where and when to begin colonizing the colon

A pair of University of Virginia School of Medicine scientists have revealed how E. coli seeks out the most oxygen-free crevices of your colon to cause the worst infection possible.

19 Aug 2019

Removal of a critical enzyme may help cases of sepsis finds research

Scientists at the University of California San Diego School of Medicine have shown that removal of an enzyme called the PH domain Leucine-rich repeat Protein Phosphatase 1 (PHLPP1) could help laboratory mice with sepsis in a model they had created for their experiment. The study titled, “PHLPP1 counter-regulates STAT1-mediated inflammatory signalling,” was published this week in the journal eLife.

15 Aug 2019

Removing single enzyme improves outcomes in mouse model of sepsis

Sepsis occurs when the body goes overboard in its attempt to fight off an infection. Immune cells rush in, overreact and wreak havoc on tissues and organs, often resulting in organ failure and death.

14 Aug 2019

Researchers examine how superbug fights last-resort antibiotics

Antibiotic resistance is one of the biggest threats to global health, food security, and development today. A new study shows how superbugs adapt to combat 'last-resort antibiotics'.

13 Aug 2019

Resistance to two critical antibiotics widely distributed in Southeast Asia

Resistance to two critical antibiotic types, one a "drug of last resort" when all others fail against some "superbugs," are widely distributed in Southeast Asia, raising the risk of untreatable infections, say a team of investigators led by Georgetown University Medical Center.

13 Aug 2019